¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"fibroblast growth factor, basic"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
realization factor
½ÇÇöÀÎÀÚ
recruitment factor
µ¿¿øÀÎÀÚ
reducing factor
ȯ¿øÀÎÀÚ
reinforcing factor
°È¿äÀÎ
relaxing factor
ÀÌ¿ÏÀÎÀÚ
radiation weighting factor
¹æ»ç¼±°¡Áß°è¼ö
resistance factor
³»¼ºÀÎÀÚ, ÀúÇ×ÀÎÀÚ
resistance transfer factor
³»¼ºÀü´ÞÀÎÀÚ
reticuloendothelial depressant factor
±×¹°³»Çǰè¾ïÁ¦ÀÎÀÚ, ¸Á»ó³»Çǰè¾ïÁ¦ÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
roentgen-to-rad conversion factor
·ÛÆ®°Õ´ë·¡µåº¯È¯°è¼ö
somatotropin release inhibiting factor
¼ºÀåÈ£¸£¸óºÐºñ¾ïÁ¦ÀÎÀÚ
spreading factor
È®»êÀÎÀÚ
stable factor
¾ÈÁ¤ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
somatotropin release inhibiting factor
¼ºÀåÈ£¸£¸óÀ¯¸®¾ïÁ¦ÀÎÀÚ
spreading factor
È®»êÀÎÀÚ
stable factor
¾ÈÁ¤ÀÎÀÚ
stroma factor
¹öÆÀÁúÀÎÀÚ
sunprotective factor
Àϱ¤º¸È£Áö¼ö
testis-determining factor
°íȯ°áÁ¤ÀÎÀÚ
therapeutic gain factor
Ä¡·áÀ̵æ°è¼ö
thyrotrophin releasing factor
¹æÆÐ»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ, °©»ó»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ
time-dose factor
½Ã°£¼±·®ÀÎÀÚ
tissue factor
Á¶Á÷ÀÎÀÚ
transfer factor
Àü´ÞÀÎÀÚ
transmission factor
Åõ°ú°è¼ö
tumor angiogenesis factor
Á¾¾çÇ÷°üÇü¼ºÀÎÀÚ
tumor necrosis factor
Á¾¾ç±«»çÀÎÀÚ
vascular permeability factor
Ç÷°üÅõ°úÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
platelet factor 4
Ç÷¼ÒÆÇÀÎÀÚ(úìá³÷ùì×í) 4
platelet factor 4=PF4
Ç÷¼ÒÆÇÀÎÀÚ 4
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
platelet-activating factor (PAF)
Ç÷¼ÒÆÇ Ȱ¼ºÈÀÎÀÚ
platelet-activating factor (paf)
Ç÷¼ÒÆÇȰ¼ºÈÀÎÀÚ(úìá³÷ùüÀàõûùì×í)
power factor
Ãâ·Â·ü(õóæ³ëÒ), ¿ª·ü(æ³ëÒ).
predisposing factor
¼ÒÀμº ¿äÀÎ, ¼±Çà¿äÀÎ.
prognostic factor
¿¹ÈÄÀÎÀÚ
prolactin inhibiting factor
ÇÁ·Ñ¶ôƾ(ºÐºñ)¾ïÁ¦ÀÎÀÚ.
prolactin inhibiting factor
ÇÁ·Î¶ôƾ¾ïÁ¦ÀÎÀÚ
prolactin-inhibitory factor(PIF)
ÇÁ·Î¶ôƾ ºÐºñ ¾ïÁ¦ ÀÎÀÚ
prolactin-releasing factor(PRF)
ÇÁ·Î¶ôƾ ºÐºñ À¯¹ß ÀÎÀÚ
protein synthesis factor
´Ü¹éÇÕ¼ºÀÎÀÚ(Ó±ÛÜùêà÷ì×í).
psychogenic factor
½ÉÀμº ¿ä¼Ò(¡é©áÈ).
psychological factor
½É¸®Àû ¿äÀÎ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
anisotropy factor
ºñµî¹æ¼º°è¼ö
antigen, colonization factor
Áý¶ôÇü¼ºÀÎÀÚÇ׿ø, ¼¼Æ÷±ºÇü¼ºÀÎÀÚÇ׿ø
antihemophilic A factor =AHA
Ç×Ç÷¿ìº´ AÀÎÀÚ(?ËöËö).
antihemophilic factor =AHF
Ç×Ç÷¿ìº´ÀÎÀÚ(¡ì×í)
antihemophilic factor =AHF
Ç×Ç÷¿ìº´ÀÎÀÚ(?ËöËö).
antihemophllic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antiinsulin factor
Ç×Àν¶¸°ÀÎÀÚ.
antineuritic factor
Ç׽Ű濰ÀÎÀÚ(ù÷ãêÌèæúì×í).
antinuclear factor =ANF
Ç×ÇÙÀÎÀÚ.
antipellagra factor
Çׯç¶ó±×¶óÀÎÀÚ.
antiphagocytic factor
Ç׎½ÄÀÎÀÚ, Ç׽ıÕÀÎÀÚ
antirachitic factor
Ç×±¸·çº´ÀÎÀÚ(¡ì×í).
antiscorbutic factor
Ç×±«Ç÷º´ÀÎÀÚ.
antisterility factor
Ç׺ÒÀÓÀÎÀÚ(ù÷ÝÕìôì×í).
antistiffness factor
Ç×°Á÷ÀÎÀÚ(ù÷ËòÁ ì×í).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
13
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½